Cancer genomics predicts disease relapse and therapeutic response to neoadjuvant chemotherapy of hormone sensitive breast cancers

Several studies provide insight into the landscape of breast cancer genomics with the genomic characterization of tumors offering exceptional opportunities in defining therapies tailored to the patient’s specific need. However, translating genomic data into personalized treatment regimens has been h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Jieqiang, Muskhelishvili, Levan, Tong, Weida, Borlak, Jürgen, Chen, Minjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235228/
https://www.ncbi.nlm.nih.gov/pubmed/32424219
http://dx.doi.org/10.1038/s41598-020-65055-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235228/
https://www.ncbi.nlm.nih.gov/pubmed/32424219
http://dx.doi.org/10.1038/s41598-020-65055-4

Ejemplares similares